TY - JOUR
T1 - Local perfusion of nicotine differentially modulates somatodendritic dopamine release in the rat ventral tegmental area after nicotine preexposure
AU - Rahman, S.
AU - Zhang, J.
AU - Corrigall, W. A.
N1 - Funding Information:
This work was supported in part by NIDA grant DA09577.
PY - 2004/9
Y1 - 2004/9
N2 - We examined the effects of nicotine perfusion into the ventral tegmental area (VTA) on extracellular dopamine (DA) levels in rats using in vivo microdialysis. Local perfusion with nicotine for 80 min (10-100 μM) modestly increased (∼105-131% of basal) the extracellular DA levels in the VTA of rats that had been pretreated with saline for 5 days. In animals that had been pretreated with nicotine for 5 days (0.3 mg/kg, s.c.), perfusion with nicotine for 80 min (10-100 μM) dose-dependently increased the extracellular DA levels in the VTA of rats and did so to a greater extent than in saline-pretreated animals (125-171% of basal). Co-perfusion through the dialysis probe with 100 μM mecamylamine, a nonselective nicotinic acetylcholine receptor (nAChR) antagonist, or 100 μM dihydro-β-erythroidine, a high affinity and competitive nAChR antagonist, attenuated the enhancement of extracellular DA levels produced by 100 μM nicotine alone. These results suggest that local nicotine challenge potentiated the somatodendritic DA release after nicotine preexposure by stimulation of high-affinity nAChRs in the VTA.
AB - We examined the effects of nicotine perfusion into the ventral tegmental area (VTA) on extracellular dopamine (DA) levels in rats using in vivo microdialysis. Local perfusion with nicotine for 80 min (10-100 μM) modestly increased (∼105-131% of basal) the extracellular DA levels in the VTA of rats that had been pretreated with saline for 5 days. In animals that had been pretreated with nicotine for 5 days (0.3 mg/kg, s.c.), perfusion with nicotine for 80 min (10-100 μM) dose-dependently increased the extracellular DA levels in the VTA of rats and did so to a greater extent than in saline-pretreated animals (125-171% of basal). Co-perfusion through the dialysis probe with 100 μM mecamylamine, a nonselective nicotinic acetylcholine receptor (nAChR) antagonist, or 100 μM dihydro-β-erythroidine, a high affinity and competitive nAChR antagonist, attenuated the enhancement of extracellular DA levels produced by 100 μM nicotine alone. These results suggest that local nicotine challenge potentiated the somatodendritic DA release after nicotine preexposure by stimulation of high-affinity nAChRs in the VTA.
KW - Dihydro-β-erythroidine
KW - dopamine
KW - in vivo microdialysis
KW - mecamylamine
KW - nicotine
KW - somatodendritic dopamine release
KW - ventral tegmental area
UR - https://www.scopus.com/pages/publications/4043099714
U2 - 10.1023/B:NERE.0000035803.64724.17
DO - 10.1023/B:NERE.0000035803.64724.17
M3 - Article
C2 - 15453263
AN - SCOPUS:4043099714
SN - 0364-3190
VL - 29
SP - 1687
EP - 1693
JO - Neurochemical Research
JF - Neurochemical Research
IS - 9
ER -